|
|
|
| Trevigen, Inc. is a rapidly growing biotechnology company focused on the development of products and technology for cancer research with emphasise on apoptosis, DNA damage and repair and cancer cell function and behavior.
The previous decade saw a phenomenal increase in the number of investigators studying apoptosis, but only recently has the link between DNA damage and apoptosis received significant attention. |
|
Trevigen supplies focused research products for
cancer research that allow researchers to study cancer cell function and behavior
including in angiogenesis, cell invasion and PARP & PARG research. Together with specifically designing assays for lead compound and genotoxic screening based on DNA damage and repair and cancer cell behavior, Trevigen is a lead provider in cancer research tools. |
|